 |
|
Early onset gene for inflammatory bowel diseases identified
September 03, 2008A study of Crohn's disease and ulcerative colitis in children has identified a gene that influences whether children get these diseases early in life, and points to a potential new target for treatment.
The findings of the international team that performed the study were published online this week by the journal Nature Genetics.
Crohn's disease and ulcerative colitis are chronic inflammatory diseases that affect the intestines, resulting in pain, severe diarrhea, intestinal bleeding, weight loss and fever. In ulcerative colitis, the inner lining of the colon is inflamed, while in Crohn's disease the inflammation extends deeper into the intestinal wall and can involve both the small and large intestine.
While several genes that influence susceptibility to the two diseases have been found previously, this study is the first to focus on inflammatory bowel disease (IBD) with childhood onset, says co-first author Subra Kugathasan, MD.
Kugathasan recently was recruited to Emory University School of Medicine's Department of Pediatrics from the Medical College of Wisconsin to head the Pediatric Inflammatory Bowel Disease program. Dr Kugathasan's future research will focus on discovery of additional IBD genes and in depth study of how these genes influence disease onset and progression.
"Our novel candidate gene is in the same inflammatory pathway as some other susceptibility genes, so it may represent an accessible target for treatment," Kugathasan says.
Kugathasan's co-first author is Robert Baldassano, MD, director of the Center for Inflammatory Bowel Disease at Children's Hospital of Philadelphia. The study's senior author is Hakon Hakonarson, MD, director of the Center for Applied Genomics at Children's Hospital of Philadelphia and associate professor of pediatrics at University of Pennsylvania School of Medicine.
Both genetics and the environment have an effect on the risk of getting inflammatory bowel disease, Kugathasan says. If one identical twin suffers from Crohn's disease, the other has a 60 percent probability of getting it too. However, the incidence of disease has drastically increased over the last half century, he notes, suggesting a key role of the environment in disease development. Smoking is an environmental factor that is particular strong in increasing the risk of Crohn's disease.
"We have to conclude that the interactions between genetics and environment are responsible for most cases," he says.
The study compared the DNA of more than 1,000 children diagnosed with inflammatory bowel diseases at the average age of 11 with 4,250 controls (disease-free children), and confirmed the findings in a larger set of patients established by the British Wellcome Trust Case Control Consortium.
The authors used gene chip microarray technology to scan thousands of one-letter alternative genetic "spellings" -- known to geneticists as single nucleotide polymorphisms (SNPs)-- spread throughout the patients' DNA. Most of the SNPs made little difference when it came to affecting the risk of inflammatory bowel disease, but a few stood out, and two had not been seen before.
One new SNP led the scientists to a gene called tumor necrosis factor receptor superfamily member 6B (TNFRSF6B), whose activity they found was associated with the degree of inflammation in the colon. The function of the second SNP is still under investigation.
TNFRSF6B encodes a protein that lengthens the duration of an immune response by regulating the longevity of activated white blood cells.
Kugathasan notes that a related protein, tumor necrosis factor alpha, is the target of an existing antibody treatment for inflammatory bowel disease. This suggests that antibodies to TNFRSF6B could also be helpful in controlling the disease, he says.
Emory University
While several genes that influence susceptibility to the two diseases have been found previously, this study is the first to focus on inflammatory bowel disease (IBD) with childhood onset, says co-first author Subra Kugathasan, MD.
Kugathasan recently was recruited to Emory University School of Medicine's Department of Pediatrics from the Medical College of Wisconsin to head the Pediatric Inflammatory Bowel Disease program. Dr Kugathasan's future research will focus on discovery of additional IBD genes and in depth study of how these genes influence disease onset and progression.
"Our novel candidate gene is in the same inflammatory pathway as some other susceptibility genes, so it may represent an accessible target for treatment," Kugathasan says.
Kugathasan's co-first author is Robert Baldassano, MD, director of the Center for Inflammatory Bowel Disease at Children's Hospital of Philadelphia. The study's senior author is Hakon Hakonarson, MD, director of the Center for Applied Genomics at Children's Hospital of Philadelphia and associate professor of pediatrics at University of Pennsylvania School of Medicine.
Both genetics and the environment have an effect on the risk of getting inflammatory bowel disease, Kugathasan says. If one identical twin suffers from Crohn's disease, the other has a 60 percent probability of getting it too. However, the incidence of disease has drastically increased over the last half century, he notes, suggesting a key role of the environment in disease development. Smoking is an environmental factor that is particular strong in increasing the risk of Crohn's disease.
"We have to conclude that the interactions between genetics and environment are responsible for most cases," he says.
The study compared the DNA of more than 1,000 children diagnosed with inflammatory bowel diseases at the average age of 11 with 4,250 controls (disease-free children), and confirmed the findings in a larger set of patients established by the British Wellcome Trust Case Control Consortium.
The authors used gene chip microarray technology to scan thousands of one-letter alternative genetic "spellings" -- known to geneticists as single nucleotide polymorphisms (SNPs)-- spread throughout the patients' DNA. Most of the SNPs made little difference when it came to affecting the risk of inflammatory bowel disease, but a few stood out, and two had not been seen before.
One new SNP led the scientists to a gene called tumor necrosis factor receptor superfamily member 6B (TNFRSF6B), whose activity they found was associated with the degree of inflammation in the colon. The function of the second SNP is still under investigation.
TNFRSF6B encodes a protein that lengthens the duration of an immune response by regulating the longevity of activated white blood cells.
Kugathasan notes that a related protein, tumor necrosis factor alpha, is the target of an existing antibody treatment for inflammatory bowel disease. This suggests that antibodies to TNFRSF6B could also be helpful in controlling the disease, he says.
Emory University
Inflammatory Bowel Disease Current Events and Inflammatory Bowel Disease News RSSAdalimumab may reduce health-care costs for Crohn's disease patients
Inflammatory bowel disease (IBD) is a term that refers to both ulcerative colitis (UC) and Crohn's disease (CD). IBD occurs most frequently in people in their late teens and twenties. There have been cases in children as young as two years old and in older adults in their seventies and eighties; men and women have an equal chance of getting the disease.
Previously unknown immune cell may help those with Crohn's and colitis
The tonsils and lymphoid tissues in the intestinal tract that help protect the body from external pathogens are the home base of a rare immune cell newly identified by researchers at Washington University School of Medicine in St. Louis.
Vitamin D deficiency common in patients with IBD, chronic liver disease
New research presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found patients with inflammatory bowel disease or chronic liver disease were at increased risk of developing Vitamin D deficiencies. Two separate studies highlight the importance of regular Vitamin D checkups in the evaluation of patients with certain digestive diseases.
Study confirms colonoscopy associated with reduced colorectal cancer incidence
Patients who undergo a complete negative colonoscopy have a reduced incidence of colorectal cancer, confirms a study published in Clinical Gastroenterology and Hepatology.
ASGE encourages patients to speak to their doctor about colorectal cancer screening options
Results of the National CT Colonography Trial, published in the September 18 issue of the New England Journal of Medicine, show improvements in the technology's ability to diagnose intermediate- to large-sized polyps in the colon, but this method of testing is not as effective in diagnosing small polyps
Consumption of nuts, corn or popcorn not associated with increased risk of diverticulosis in men
Contrary to a common recommendation to avoid eating popcorn, nuts and corn to prevent diverticular complications, a large prospective study of men indicates that the consumption of these foods does not increase the risk of diverticulosis or diverticular complications, according to a study in the August 27 issue of JAMA.
New study shows health benefits of probiotic could extend to the entire body
Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin.
Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model.
Biodegradable polymers show promise for improving treatment of acute inflammatory diseases
A family of biodegradable polymers called polyketals and their derivatives may improve treatment for such inflammatory illnesses as acute lung injury, acute liver failure and inflammatory bowel disease by delivering drugs, proteins and snips of ribonucleic acid to disease locations in the body.
Obesity raises risks of serious digestive health concerns
The prevalence of obesity and overweight in the United States coupled by the increased risk of gastrointestinal diseases related to obesity raises serious implications for the health of Americans.
More Inflammatory Bowel Disease Current Events and Inflammatory Bowel Disease News Articles
 | Inflammatory Bowel Disease: From Bench to Bedside Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the... |
 | Kirsner's Inflammatory Bowel Diseases (Inflammatory Bowel Disease (Kirsner)) by R. Balfour Sartor, William Sandborn This comprehensive New Edition describes all of the latest scientific and clinical advances in the field of inflammatory bowel disease (IBD). A new editorial teamjoined by a superb group of international authoritiesexamine every aspect of IBDincluding etiology and pathogenesis, diagnosis and evaluation, medical and surgical therapy, and more. A wealth of expanded coverage, additional... |
 | Pocket Guide to Inflammatory Bowel Disease Patients with Inflammatory Bowel Disease (IBD) present special challenges for practitioners, whether in the office, in the clinic, or on the telephone. This easy to read, easy to use pocket guide has been written by respected clinicians to help anyone who cares for IBD patients identify key problems and make decisions about treatment. Each chapter is devoted to a particular complaint or symptom... |
 | Inflammatory Bowel Diseases by Jack Satsangi, Lloyd R. Sutherland This brand new text covers all aspects of the diagnosis and medical treatment of inflammation bowel disease, clinical signs, disease activity and progress, reoccurrence, complications, and nutritional aspects, diagnosis, medical treatments, and new surgical techniques. It offers up-to-date information on epidemiology, genetics, immunology, etiology, and pathogenesis of the disease. Hundreds of... |
 | Immune Mechanisms in Inflammatory Bowel Disease (Advances in Experimental Medicine and Biology) Immune Mechanisms in Inflammatory Bowel Disease is a highly, concise update of the most recent advances in the immunobiology, genetics and microbiology related to Inflammatory Bowel Disease. This book broadly treats the topics that lead to understanding of the pathogenesis of this disease in an organized, systematic approach.... |
 | Check Your Pride at the Door: Learning to Live With inflammatory Bowel Disease by Dr. Darryl D. Helems Check Your Pride at the Door and learn how to live with inflammatory bowel disease (IBD). After you have read the research, experienced the medical procedures, changed your diet, or started taking the medication, the reality is that you still have to live each day with a chronic illness. In Check Your Pride at the Door, the author describes how he has lived with IBD for twenty years and provides... |
 | Inflammatory Bowel Disease (Facts) by Louise Langmead, Peter Irving Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, affects 1 person in every 400 in the UK. Between 6,000 and 12,000 new cases of ulcerative colitis are diagnosed every year, and research shows that the number of people with Crohn's disease has been rising steadily. While there are numerous volumes covering the management of IBD aimed at clinicians and... |
 | Healing Inflammatory Bowel Disease by Paul Nison New 2008 Edition, now available. Answers to questions about Inflammatory Bowel Disease from a former sufferer that was healed through nature's cure. In this new book Paul Nison shares how he cured himslef o finflammatory bowel disease (IBD) alson known as Crohn's disease and ulcerative colitis. Paul has discovered a natural cure fo rthis so called incurable disease. He will tell you what he... |
 | Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation (Falk Symposium) Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic inflammatory bowel diseases (IBD), that has changed or will change in the future the diagnostic and therapeutic approach in these diseases. The relevance of classical conventional IBD therapies has been critically re-evaluated under criteria of evidence-based medicine approaches. On the other hand,... |
 | Inflammatory Bowel Disease (Clinical Gastroenterology) (Clinical Gastroenterology) World-renowned clinicians provide a comprehensive yet concise overview of the myriad of issues surrounding inflammatory bowel diseases, Crohn's disease, and ulcerative colitis. Writing in a language accessible to those both within and without the medical community, these experienced physicians fully explain what IBD is, why it does what it does, how to treat it, and when it is necessary to... |
| © 2008 BrightSurf.com |